Americagene is a human systems biology drug discovery company harnessing the bioinformatics content and processing power of living human cell systems to rapidly decipher the functions of genes, proteins and drugs for more efficient and predictive pharmaceutical discovery. Americagene's proprietary technologies are being applied for the identification, validation and commercialization of novel and improved human therapeutics. Americagene's platform of human primary cell culture-based technologies utilize an innovative complex systems biology approach for earlier and more accurate selection of targets and compounds at all stages of preclinical and clinical development. With these, the company expects to dramatically reduce the time and cost of preclinical and clinical drug development, initially in the areas of inflammation, cardiovascular disease and oncology.